Conflict of interest

CME and CPE - Earn SMC and European CME Credits:

1. EACCME

The IOF Regionals Singapore '16' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

The 'IOF Regionals Singapore '16' is designated for a maximum of 22* hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

* If you only participate in the pre-meeting Osteoporosis Essentials Course, you should only claim 9 hours of European external CME Credits.

2. Singapore Medical Council Accreditation

The IOF Regionals, 6th Asia-Pacific Osteoporosis Meeting has been accredited a maximum of 9 CME/CPE points. Each health professional must claim only those credits that he/she actually spent in the activity. Attendees who wish to claim their SMC CME Credits need to sign and register their MCR numbers at the specific SMC desk (outside plenary room) at the beginning of each morning and afternoon sessions.

PROGRAMME

(as July 29, subject to change)

Friday November 4, 2016

10:30-12:05

Plenary Hall,
Level 4

Plenary Session I – Nutrition, Bone & Muscle
Chairs: M Chandran & JA Kanis

Nutritional Aspects during Development: Scope for prevention of bone fragility
C Cooper (UK)

Life Course Approach to Nutrition for Skeletal Health
B Dawson-Hughes (USA)

Nutritional and Physical Recommendations for Muscle Health in Seniors
R Rizzoli (CHE)

Oral Communications Selected from Abstracts x 2

OC01 - Cortical and Trabecular Deterioration Identify Women at Imminent Risk for Fracture: The prospective OFELY study
R Zebaze*, S Boutroy, E Sornay-Rendu, E Seeman, R Chapurlat

OC02 - Imminent Major Osteoporotic and Clinical Vertebral Fracture Risk after Fracture (Reykjavik Study)
H Johansson*, K Siggeirsdottir, N Harvey, A Odén, V Gudnason, E McCloskey, G Sigurdsson, J Kanis

12:05–13:05

Plenary Hall,
Level 4

Industry-Sponsored Lunch Symposium

13:05–13:45

Exhibition Level 4

Coffee/Tea Time
Poster Viewing Session (P100-P175)
Office Hours
with SB Chionh, JK Lee, E McCloskey
Poster Tour led by R Rizzoli

13:45–15:30

Plenary Hall,
Level 4

Plenary Session II: Sarcopenia
Chairs: B Dawson-Hughes & JK Lee

Towards an Operational Definition of Sarcopenia
JA Kanis (UK)

Where are we in the Development of Treatments for Sarcopenia?
J-Y Reginster (BEL)

Nutrition and frailty in the Asian context - Vitamin D and other Nutrients
N. Tandon (IND)

 

Oral Communications Selected from Abstracts x 3

OC03 - Association between Statin Use and Change in Grip Strength among Community Dwelling Older Men and Women from Hong Kong MROS Cohort Study
L Zhu*, J Leung, T Chi Yui Kwok

OC04 - Longitudinal Study of Sarcopenic Obesity and Incident Falls and Fractures in Older Men: The concord health and ageing in men project
D Scott*, V Hirani, F Blyth, V Naganathan, D Le Couteur, P Ebeling, L Waite, D Handelsman, M Seibel, R Cumming

OC05 - Fracture Liaison Service decreases Mortality after Hip Fracture
C-H Chen* S-Y Lin, J-C Chen, T-C Lee, C-J Ho

15:30–16:00

Poster Tour led by S Ferrari
Exhibition
 

16:00–17:15

Plenary Hall,
Level 4

Plenary Session III: Bone and Diabetes
Chairs: SB Chionh & S Ferrari

Bone Fragility in Patients with Diabetes: Is it bone density or bone quality?
E Seeman (AUS)

Diabetes, Obesity and Bone Mineral Density – Asia Versus the West
A Mithal (IND)

Clinical Management of Diabetes Patients with Osteoporosis
M Chandran (SGP)

17:15–18:15

Plenary Hall,
Level 4

Industry-Sponsored Symposium

18:15 - 19:00

Plenary Hall,
Level 4

Welcome Ceremony

19:00 - 20:15

Exhibition

Welcome Reception

 

Saturday November 5, 2016

08:00–09:00

 

 

Meet-The-Expert

Room 330 Level 3
  • Obesity & Bone
  • C-H Wu (TWN)
Room 335
  • Bone Microarchitecture Assessment
  • E Seeman (AUS)
Room 331
  • Exercise Post Fracture
  • JK Lee (MYS)
Room 333
  • Management of Osteoporosis Renal Failure
  • M Chandran (SGP)
Room 333
  • How to Evaluate Sarcopenia
  • O Bruyère (BEL)
Room 332
  • Drug Holidays, Sequential and Combined Therapy
  • T Matsumoto (JPN)

 

 

09:00-10:35

Plenary Hall,
Level 4

PLENARY SESSION IV: Post Fracture Management
Chairs: S Rojanasthien & C Cooper

Management of Non-Union Fracture: New orthobiologics
D Murphy (SGP)

Atypical Femoral Fracture in Asia: How to prevent? How to treat?
S Das De (SGP)

Non-Pharmacological Measures and Rehabilitation in Fractured Patients
B Dawson-Hughes (USA)

Oral Communications Selected from Abstracts x 2

OC06 - Treatment Patterns in Patients with Osteoporosis at High Risk of Fracture in Japan: A retrospective chart review
A Miyauchi*, S Fujiwara, E Hamaya, RJ Nicholls, A Weston, S Baidya, G Tran, L Pinto, RL Barron, J Takada

OC07 - Menopausal Bone Loss is mainly Cortical, not Trabecular, and does not attenuate the Heritable Component of Variance in this Microarchitecture: A prospective study of twins
E Seeman*, Å Bjørnerem, X Wang, M Bui, A Ghasem-Zadeh, R Zebaze, JL Hopper

10:35–11:20 Break / Exhibition

11:20–12:55

Plenary Hall,
Level 4

Plenary Session V: Emerging Concept I – Patients at Imminent High Risk
Chairs: C-H Wu and E Seeman

What is the Profile of Patients at Imminent High Risk of Fracture?
E McCloskey (UK)

What is the Risk of Re-Fracture among Asians?
S Lekamwasam (LKA)

Fracture Prevention in the Imminent High Risk Patients: What is the evidence (Subgroup Analyses of the RCTs)
P Ebeling (AUS)

Oral Communications Selected from Abstracts

OC08 - Biochemical Markers as Predictors of Bone Histomorphometric Alterations in Patients with Chronic Kidney Disease
M Feola*, C Rao, M Celi, E Gasbarra, U Tarantino

OC09 - Genetic Risk Score based on the Prevalence of Vertebral Fracture in Japanese Women with Osteoporosis
H Zhou*, S Mori, M Kubo, H Ito

12:55–13:55

Plenary Hall,
Level 4

Industry-Sponsored Lunch Symposium

13:55–14:40

Exhibition

Coffee/Tea Time
Committee of National Societies Highlight Session chaired by JY Reginster
Office Hours with M Chandran, B Dawson-Hughes, P Ebeling, N Tandon
Exhibition
Poster Viewing Session (P176-P251)

14:40–15:40

Plenary Hall,
Level 4

Young Investigator Award Session
Chairs: S Ferrari & A Mithal

OC10 - Promoter Hypermethylation Mediated Suppression of Cyclin Dependent Kinase Inhibitors (CDKN2A and CDKN2B) in Sporadic Parathyroid Tumors
P Singh*, A Arya, S Bhadada, U Saikia, N Sachdeva, D Dahiya, A Behera, A Bhansali

OC11 - Moderate-to-vigorous Physical Activitiy but not Sedentary Time is associated with Musculoskeletal Health Outcomes in a Cohort of Australian Middle-aged Women
F Wu*, K Wills, L Laslett, B Oldenburg, G Jones, T Winzenberg

OC12 - Health Literacy and Uptake of Dietary Calcium Recommendations in Women
SM Hosking*, R Buchbinder, J Pasco, N Hyde, L Williams, S Brennan-Olsen

OC13 - The Improved Clinical Use of Trabecular Bone Score adjusted FRAX® to predict Major Osteoporotic Fractures in Chinese Older People
Y Su*, J Leung, D Hans, O Lamy, T Kwok

OC14 - Can ALP be the Surrogate Marker for Bone Turnover?
H Tanigawa*, N Okumura, K Nishizawa, S Nishiwaki, Y Tamagawa, S Imai

15:40–16:25

Exhibition

Non-Communicable Disease Spotlight

Addressing Osteoporosis as Part of the NCD Response:Successful Approaches for Integrated Prevention and Care

16:25–17:45

Plenary Hall,
Level 4

Plenary Session VI: Roundtable Secondary Fracture Prevention
Chairs: TC Lau & P Ebeling

Implementing a Fracture Liaison Service
C Cooper (UK)

Panel Discussion

Fracture Liaison Service in Asia-Pacific Region

  • A Suzuki (JPN) & T Matsumoto (JPN)
  • C-H Wu & D-C Chan (TWN)
  • JK Lee (MYS)
  • S Rojanasthien (THA)
  • T Gunawan (IDN)
  • P Ebeling (AUS)
  • TC Lau (SGP)

 

Sunday November 6, 2016

08:00–09:00

 

 

Meet-The-Expert

Room 330 Level 3
  • Bone and Cancer
  • R Rizzoli (CHE)
Room 335
  • Vitamin D, How Much is Too Much?
  • N Tandon (IND)
Room 334
  • Glucocorticoid Induced Osteoporosis
  • SS Yeap (MYS)
Room 333
  • How to Write a Paper and Get It Published                                                    
  • E Seeman (AUS)
Room 332
  • Premenopausal Osteoporosis
  • SB Chionh (SGP)

 

09:00–10:35

Plenary Hall,
Level 4

Plenary Session VII: Treatments
Chairs: E McCloskey & N Tandon

Long Term Management of Osteoporosis
J-M Kaufman (BEL)

Novel Treatments: Odanacatib and anti-sclerostin antibodies
E Seeman (AUS)

New and Old PTH-Like Therapies for Osteoporosis: Abaloparatide and teriparatide
S Ferrari (CHE)

Oral Communications Selected from Abstracts

OC15 - Bone Health and Liver Disease - Are all Chronic Liver Diseases the same? S Khan*, S Hayat, A Bennett, N Guha, I Pande

OC16 - Identification of Chronic Joint Pain and Handgrip Strength as Independent Predictors of Osteoporosis in Middle-aged Singaporean Women
S Logan*, KL Wai, WPP Thu, W Yue, SM Sabai, TY Ling, S Fearns Smagula, JA Cauley, YE Leong

10:35–11:20

Exhibition

Poster Tour led by A Mithal

11:20–12:30

Plenary Hall,
Level 4

Plenary Session VIII: Emerging Concept II – Treat-to-target
Chairs: J-Y Reginster & FL Hew

Treat-to-target in Osteoporosis and Other Chronic Disorders: Opportunities and challenges
E McCloskey (UK)

Is Areal BMD a Good Surrogate to Evaluate Fracture Risk on Therapy?
S Ferrari (CHE)

Current Strategies and Therapies to Improve Bone Strength (Incl. Combined Sequential Therapies)
R Rizzoli (CHE)
 

12:30–13:30

Plenary Hall,
Level 4

IOF-ISCD Joint Session 
Co-chairs:  FL Hew & C Cooper
 
Non traditional/Novel  DXA applications such as TBS, Hip Axis Length/FEA
M Chandran (SGP)
 
Fracture risk Assessment: Current use of FRAX in Asia-Pacific and its potential future modifications
S Lekamwasam (LKA)
 
Best Practices for Dual-Energy X-ray Absorptiometry, Measurement and Reporting
JK Lee (MYS)

13:30–14:00

Exhibition

Coffee/Tea Time
Awards for best CNS booth and best Oral Communication chaired by P Halbout
Exhibition

14:00–15:20

Plenary Hall,
Level 4

Plenary Session IX: Orthogeriatrics
Chairs: SP Chan & R Rizzoli

Fracture in the Elderly: Surgery or conservative management?
T Nakamura (JPN)

What is the Evidence for Efficacy of Osteoporosis Drugs in the Elderly?
J-Y Reginster (BEL)

How to Optimize Care in Hip Fracture Patients : The Singaporean experience
H. K. Doshi (SGP)

15:15 Closing

Additional information

Pre-meeting course: Osteoporosis: Essentials of Densitometry, Diagnosis and Management Course

November 2-3 2016 – Suntec Singapore Convention & Exhibition Centre (Room 331)